BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36608744)

  • 1. Human glycoprotein-2 expressed in Brunner glands - A putative autoimmune target and link between Crohn's and coeliac disease.
    Roggenbuck D; Goihl A; Sowa M; Lopens S; Rödiger S; Schierack P; Conrad K; Sommer U; Jöhrens K; Grützmann R; Reinhold D; Laass MW
    Clin Immunol; 2023 Feb; 247():109214. PubMed ID: 36608744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of Crohn's disease-related anti-glycoprotein 2 antibodies in patients with celiac disease.
    Roggenbuck D; Vermeire S; Hoffman I; Reinhold D; Schierack P; Goihl A; von Arnim U; De Hertogh G; Polymeros D; Bogdanos DP; Bossuyt X
    Clin Chem Lab Med; 2015 Aug; 53(9):1349-57. PubMed ID: 25411995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease.
    Roggenbuck D; Hausdorf G; Martinez-Gamboa L; Reinhold D; Büttner T; Jungblut PR; Porstmann T; Laass MW; Henker J; Büning C; Feist E; Conrad K
    Gut; 2009 Dec; 58(12):1620-8. PubMed ID: 19549613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn's disease of the pouch.
    Cummings D; Cruise M; Lopez R; Roggenbuck D; Jairath V; Wang Y; Shen B; Rieder F
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1251-1259. PubMed ID: 30411391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease.
    Röber N; Noß L; Goihl A; Reinhold D; Jahn J; de Laffolie J; Johannes W; Flemming GM; Roggenbuck D; Conrad K; Laass MW
    Inflamm Bowel Dis; 2017 Sep; 23(9):1624-1636. PubMed ID: 28691939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.
    Bogdanos DP; Roggenbuck D; Reinhold D; Wex T; Pavlidis P; von Arnim U; Malfertheiner P; Forbes A; Conrad K; Laass MW
    BMC Gastroenterol; 2012 Aug; 12():102. PubMed ID: 22866900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brunner gland inflammation in Crohn's disease and Celiac disease: Overlapping inflammatory patterns suggest a possible link.
    AbdullGaffar B; Farhan R
    Ann Diagn Pathol; 2023 Jun; 64():152133. PubMed ID: 37019032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease.
    Roggenbuck D; Reinhold D; Wex T; Goihl A; von Arnim U; Malfertheiner P; Büttner T; Porstmann T; Porstmann S; Liedvogel B; Bogdanos DP; Laass MW; Conrad K
    Clin Chim Acta; 2011 Apr; 412(9-10):718-24. PubMed ID: 21195704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease.
    Pavlidis P; Romanidou O; Roggenbuck D; Mytilinaiou MG; Al-Sulttan F; Liaskos C; Smyk DS; Koutsoumpas AL; Rigopoulou EI; Conrad K; Forbes A; Bogdanos DP
    Clin Dev Immunol; 2012; 2012():640835. PubMed ID: 23118780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenome of coeliac disease vs. inflammatory bowel disease.
    Kleinjans M; Schneider CV; Bruns T; Strnad P
    Sci Rep; 2022 Aug; 12(1):14572. PubMed ID: 36028550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DQ: Celiac disease
    Bosca-Watts MM; Minguez M; Planelles D; Navarro S; Rodriguez A; Santiago J; Tosca J; Mora F
    World J Gastroenterol; 2018 Jan; 24(1):96-103. PubMed ID: 29358886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, Abundance, and Virulence of Adherent-Invasive
    López-Siles M; Camprubí-Font C; Gómez Del Pulgar EM; Sabat Mir M; Busquets D; Sanz Y; Martinez-Medina M
    Front Immunol; 2022; 13():748839. PubMed ID: 35359974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Potential of Zymogen Granule Glycoprotein 2 Antibodies as Serologic Biomarkers in Chinese Patients With Crohn Disease.
    Zhang S; Wu Z; Luo J; Ding X; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
    Medicine (Baltimore); 2015 Oct; 94(42):e1654. PubMed ID: 26496271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's Disease.
    Degenhardt F; Dirmeier A; Lopez R; Lang S; Kunst C; Roggenbuck D; Reinhold D; Szymczak S; Rogler G; Klebl F; Franke A; Rieder F
    Inflamm Bowel Dis; 2016 Nov; 22(11):2648-2657. PubMed ID: 27753692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
    Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
    J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2.
    Komorowski L; Teegen B; Probst C; Aulinger-Stöcker K; Sina C; Fellermann K; Stöcker W
    J Crohns Colitis; 2013 Nov; 7(10):780-90. PubMed ID: 23140841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease.
    Laass MW; Röber N; Range U; Noß L; Roggenbuck D; Conrad K
    PLoS One; 2015; 10(6):e0128104. PubMed ID: 26047356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of Crohn's disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae.
    Duman AE; Hülagü S; Çelebi A; Korkmaz U; Musul MM; Şentürk Ö; Şirin G; Yılmaz H; Koç DÖ; Dindar G; Öztürkler M; Bozkurt N; Kır HM
    Turk J Gastroenterol; 2019 Jan; 30(1):21-27. PubMed ID: 30465525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn's Disease.
    Shpoliansky M; Roggenbuck D; Pinsker M; Salamon N; Weiss B; Shouval DS; Werner L
    Dig Dis Sci; 2021 Aug; 66(8):2619-2626. PubMed ID: 32886311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Novel Crohn's Disease Marker Anti-GP2 Antibody Is Associated with Ileocolonic Location of Disease.
    Somma V; Ababneh H; Ababneh A; Gatti S; Romagnoli V; Bendia E; Conrad K; Bogdanos DP; Roggenbuck D; Ciarrocchi G
    Gastroenterol Res Pract; 2013; 2013():683824. PubMed ID: 23762038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.